Analysts Set Inozyme Pharma, Inc. (NASDAQ:INZY) Price Target at $11.75
Shares of Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]
Shares of Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]
